Evaluation and treatment of fever in the non-neutropenic child with cancer

Wanda Salzer, Seth M. Steinberg, David J. Liewehr, Alison Gail Freifeld, Frank M. Balis, Brigitte C. Widemann

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To document the current approach to the evaluation and treatment of febrile non-neutropenic children with cancer by surveying American Society of Pediatric Hematology/Oncology (ASPHO) members. Methods: Five hundred ninety-five ASPHO members were sent questionnaires polling their current practices in the evaluation and treatment of clinically stable, febrile (oral temperature of 38°C x2, or ≥38.3°C), non-neutropenic (absolute neutrophil count >500/μL) pediatric cancer patients who have no identifiable bacterial infection. Patients were assigned to one of four groups based on the presence or absence of a central venous catheter (CVC) and no source (NS) or presumed viral source (VS) for fever. Results: Three hundred sixteen ASPHO members (53%) responded and 300 questionnaires were evaluable. If a CVC was present, respondents universally drew blood cultures (99% NS, 96% VS) from the CVC, but only one third drew peripheral blood cultures (33% NS, 29% VS). If a CVC was not present, the majority of respondents (80% NS, 61% VS) drew peripheral cultures. ASPHO members started empiric antibiotics more frequently in patients with a CVC (69% NS, 55% VS) than in patients without a CVC (33% NS, 23% VS). Most did not admit these patients to the hospital (40% CVC and NS, 33% CVC and VS, 22% no CVC and NS, 19% no CVC and VS). ASPHO members with more years of experience were more likely to obtain peripheral blood cultures if a CVC was present and to admit a patient without a CVC. Conclusions: Nearly all respondents obtained a blood culture from the CVC in the initial assessment of the febrile, non-neutropenic patient with a CVC, but other evaluation and management practices varied considerably.

Original languageEnglish (US)
Pages (from-to)606-612
Number of pages7
JournalJournal of Pediatric Hematology/Oncology
Volume25
Issue number8
DOIs
StatePublished - Aug 1 2003

Fingerprint

Central Venous Catheters
Fever
Neoplasms
Hematology
Pediatrics
Therapeutics
Practice Management
Bacterial Infections

Keywords

  • Cancer
  • Children
  • Fever
  • Non-neutropenia
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Evaluation and treatment of fever in the non-neutropenic child with cancer. / Salzer, Wanda; Steinberg, Seth M.; Liewehr, David J.; Freifeld, Alison Gail; Balis, Frank M.; Widemann, Brigitte C.

In: Journal of Pediatric Hematology/Oncology, Vol. 25, No. 8, 01.08.2003, p. 606-612.

Research output: Contribution to journalArticle

Salzer, Wanda ; Steinberg, Seth M. ; Liewehr, David J. ; Freifeld, Alison Gail ; Balis, Frank M. ; Widemann, Brigitte C. / Evaluation and treatment of fever in the non-neutropenic child with cancer. In: Journal of Pediatric Hematology/Oncology. 2003 ; Vol. 25, No. 8. pp. 606-612.
@article{8eb0fafaf9bb4cb988eb43b3bd5537c1,
title = "Evaluation and treatment of fever in the non-neutropenic child with cancer",
abstract = "Purpose: To document the current approach to the evaluation and treatment of febrile non-neutropenic children with cancer by surveying American Society of Pediatric Hematology/Oncology (ASPHO) members. Methods: Five hundred ninety-five ASPHO members were sent questionnaires polling their current practices in the evaluation and treatment of clinically stable, febrile (oral temperature of 38°C x2, or ≥38.3°C), non-neutropenic (absolute neutrophil count >500/μL) pediatric cancer patients who have no identifiable bacterial infection. Patients were assigned to one of four groups based on the presence or absence of a central venous catheter (CVC) and no source (NS) or presumed viral source (VS) for fever. Results: Three hundred sixteen ASPHO members (53{\%}) responded and 300 questionnaires were evaluable. If a CVC was present, respondents universally drew blood cultures (99{\%} NS, 96{\%} VS) from the CVC, but only one third drew peripheral blood cultures (33{\%} NS, 29{\%} VS). If a CVC was not present, the majority of respondents (80{\%} NS, 61{\%} VS) drew peripheral cultures. ASPHO members started empiric antibiotics more frequently in patients with a CVC (69{\%} NS, 55{\%} VS) than in patients without a CVC (33{\%} NS, 23{\%} VS). Most did not admit these patients to the hospital (40{\%} CVC and NS, 33{\%} CVC and VS, 22{\%} no CVC and NS, 19{\%} no CVC and VS). ASPHO members with more years of experience were more likely to obtain peripheral blood cultures if a CVC was present and to admit a patient without a CVC. Conclusions: Nearly all respondents obtained a blood culture from the CVC in the initial assessment of the febrile, non-neutropenic patient with a CVC, but other evaluation and management practices varied considerably.",
keywords = "Cancer, Children, Fever, Non-neutropenia, Treatment",
author = "Wanda Salzer and Steinberg, {Seth M.} and Liewehr, {David J.} and Freifeld, {Alison Gail} and Balis, {Frank M.} and Widemann, {Brigitte C.}",
year = "2003",
month = "8",
day = "1",
doi = "10.1097/00043426-200308000-00004",
language = "English (US)",
volume = "25",
pages = "606--612",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Evaluation and treatment of fever in the non-neutropenic child with cancer

AU - Salzer, Wanda

AU - Steinberg, Seth M.

AU - Liewehr, David J.

AU - Freifeld, Alison Gail

AU - Balis, Frank M.

AU - Widemann, Brigitte C.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Purpose: To document the current approach to the evaluation and treatment of febrile non-neutropenic children with cancer by surveying American Society of Pediatric Hematology/Oncology (ASPHO) members. Methods: Five hundred ninety-five ASPHO members were sent questionnaires polling their current practices in the evaluation and treatment of clinically stable, febrile (oral temperature of 38°C x2, or ≥38.3°C), non-neutropenic (absolute neutrophil count >500/μL) pediatric cancer patients who have no identifiable bacterial infection. Patients were assigned to one of four groups based on the presence or absence of a central venous catheter (CVC) and no source (NS) or presumed viral source (VS) for fever. Results: Three hundred sixteen ASPHO members (53%) responded and 300 questionnaires were evaluable. If a CVC was present, respondents universally drew blood cultures (99% NS, 96% VS) from the CVC, but only one third drew peripheral blood cultures (33% NS, 29% VS). If a CVC was not present, the majority of respondents (80% NS, 61% VS) drew peripheral cultures. ASPHO members started empiric antibiotics more frequently in patients with a CVC (69% NS, 55% VS) than in patients without a CVC (33% NS, 23% VS). Most did not admit these patients to the hospital (40% CVC and NS, 33% CVC and VS, 22% no CVC and NS, 19% no CVC and VS). ASPHO members with more years of experience were more likely to obtain peripheral blood cultures if a CVC was present and to admit a patient without a CVC. Conclusions: Nearly all respondents obtained a blood culture from the CVC in the initial assessment of the febrile, non-neutropenic patient with a CVC, but other evaluation and management practices varied considerably.

AB - Purpose: To document the current approach to the evaluation and treatment of febrile non-neutropenic children with cancer by surveying American Society of Pediatric Hematology/Oncology (ASPHO) members. Methods: Five hundred ninety-five ASPHO members were sent questionnaires polling their current practices in the evaluation and treatment of clinically stable, febrile (oral temperature of 38°C x2, or ≥38.3°C), non-neutropenic (absolute neutrophil count >500/μL) pediatric cancer patients who have no identifiable bacterial infection. Patients were assigned to one of four groups based on the presence or absence of a central venous catheter (CVC) and no source (NS) or presumed viral source (VS) for fever. Results: Three hundred sixteen ASPHO members (53%) responded and 300 questionnaires were evaluable. If a CVC was present, respondents universally drew blood cultures (99% NS, 96% VS) from the CVC, but only one third drew peripheral blood cultures (33% NS, 29% VS). If a CVC was not present, the majority of respondents (80% NS, 61% VS) drew peripheral cultures. ASPHO members started empiric antibiotics more frequently in patients with a CVC (69% NS, 55% VS) than in patients without a CVC (33% NS, 23% VS). Most did not admit these patients to the hospital (40% CVC and NS, 33% CVC and VS, 22% no CVC and NS, 19% no CVC and VS). ASPHO members with more years of experience were more likely to obtain peripheral blood cultures if a CVC was present and to admit a patient without a CVC. Conclusions: Nearly all respondents obtained a blood culture from the CVC in the initial assessment of the febrile, non-neutropenic patient with a CVC, but other evaluation and management practices varied considerably.

KW - Cancer

KW - Children

KW - Fever

KW - Non-neutropenia

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0042069781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042069781&partnerID=8YFLogxK

U2 - 10.1097/00043426-200308000-00004

DO - 10.1097/00043426-200308000-00004

M3 - Article

C2 - 12902912

AN - SCOPUS:0042069781

VL - 25

SP - 606

EP - 612

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 8

ER -